AstraZeneca
AZN
AZN
1,363 hedge funds and large institutions have $150B invested in AstraZeneca in 2026 Q1 according to their latest regulatory filings, with 288 funds opening new positions, 107 increasing their positions, 965 reducing their positions, and 289 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
3% less funds holding
Funds holding: 1,402 → 1,363 (-39)
41% less call options, than puts
Call options by funds: $856M | Put options by funds: $1.45B
89% less repeat investments, than reductions
Existing positions increased: 107 | Existing positions reduced: 965
Holders
1,363
Holding in Top 10
71
Calls
$856M
Puts
$1.45B
Top Buyers
| 1 | +$8.37B | |
| 2 | +$4.44B | |
| 3 | +$4.14B | |
| 4 |
Capital International Investors
Los Angeles,
California
|
+$3.22B |
| 5 |
Amundi
Paris,
France
|
+$2.49B |
Top Sellers
| 1 | -$4.73B | |
| 2 | -$3.03B | |
| 3 | -$1.74B | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$1.18B |
| 5 |
Sanders Capital
West Palm Beach,
Florida
|
-$1.15B |
